金河生物15日(ri)晚間公告,預計2016年1-9月實現歸屬(shu)于上市(shi)公司股東(dong)的凈利(li)潤11,671.86萬元至14,418.18萬元,同比(bi)增長70%至110%。
公(gong)告披露,除(chu)子公(gong)司(si)(si)內(nei)蒙古金(jin)河生(sheng)物制品有(you)限公(gong)司(si)(si)完(wan)(wan)成收購(gou)杭州佑公(gong)司(si)(si)67%股權(quan)時間(jian)較短,各項資源還在整合,技術改造(zao)初步完(wan)(wan)成,盈(ying)利(li)能力(li)尚未體現外(wai),其余(yu)各主要子公(gong)司(si)(si)經營(ying)狀況趨(qu)好(hao),主營(ying)業務收入(ru)(ru)和利(li)潤水平比(bi)上年同期會有(you)所增長(chang);母(mu)公(gong)司(si)(si)產品由于(yu)市場需求(qiu)有(you)向好(hao)的(de)(de)(de)趨(qu)勢,銷(xiao)售收入(ru)(ru)會有(you)所增長(chang),部(bu)分原材(cai)料(liao)價格(ge)仍(reng)處于(yu)低位(wei),生(sheng)產技術水平不(bu)斷提(ti)高,生(sheng)產成本下(xia)降明顯,利(li)潤水平提(ti)升較快;匯率變動(dong)具有(you)不(bu)確定(ding)(ding)性,對(dui)母(mu)公(gong)司(si)(si)以美元結算的(de)(de)(de)銷(xiao)售收入(ru)(ru)以及(ji)子公(gong)司(si)(si)法瑪威的(de)(de)(de)外(wai)幣報表(biao)折算會產生(sheng)一(yi)定(ding)(ding)影響;三季度(du)的(de)(de)(de)季節性檢修時間(jian)預計比(bi)上年同期短,停工(gong)損失減少。故(gu)預測2016年1-9月歸屬(shu)于(yu)上市公(gong)司(si)(si)股東的(de)(de)(de)凈利(li)潤增長(chang)幅度(du)與上年同期相比(bi)在70%~110%的(de)(de)(de)范(fan)圍內(nei)浮動(dong)。
2016年(nian)(nian)上(shang)(shang)(shang)半年(nian)(nian)公(gong)司實現銷售(shou)收入69,666萬元,比上(shang)(shang)(shang)年(nian)(nian)同(tong)期增長26.36%;歸屬于上(shang)(shang)(shang)市公(gong)司股東的凈(jing)利潤(run)9,423萬元,比上(shang)(shang)(shang)年(nian)(nian)同(tong)期增長85.04%。
中(zhong)(zhong)(zhong)(zhong)(zhong)證(zheng)網(wang)聲(sheng)明(ming)(ming):凡(fan)本(ben)(ben)網(wang)注明(ming)(ming)“來源(yuan)(yuan):中(zhong)(zhong)(zhong)(zhong)(zhong)國證(zheng)券報(bao)·中(zhong)(zhong)(zhong)(zhong)(zhong)證(zheng)網(wang)”的(de)所有(you)作(zuo)(zuo)品,版權均(jun)屬于中(zhong)(zhong)(zhong)(zhong)(zhong)國證(zheng)券報(bao)、中(zhong)(zhong)(zhong)(zhong)(zhong)證(zheng)網(wang)。中(zhong)(zhong)(zhong)(zhong)(zhong)國證(zheng)券報(bao)·中(zhong)(zhong)(zhong)(zhong)(zhong)證(zheng)網(wang)與作(zuo)(zuo)品作(zuo)(zuo)者(zhe)(zhe)聯合聲(sheng)明(ming)(ming),任何組織未(wei)經中(zhong)(zhong)(zhong)(zhong)(zhong)國證(zheng)券報(bao)、中(zhong)(zhong)(zhong)(zhong)(zhong)證(zheng)網(wang)以(yi)及作(zuo)(zuo)者(zhe)(zhe)書面授權不(bu)(bu)得(de)轉(zhuan)載(zai)、摘(zhai)編或(huo)利(li)(li)用(yong)其(qi)(qi)它方式使用(yong)上述作(zuo)(zuo)品。凡(fan)本(ben)(ben)網(wang)注明(ming)(ming)來源(yuan)(yuan)非中(zhong)(zhong)(zhong)(zhong)(zhong)國證(zheng)券報(bao)·中(zhong)(zhong)(zhong)(zhong)(zhong)證(zheng)網(wang)的(de)作(zuo)(zuo)品,均(jun)轉(zhuan)載(zai)自其(qi)(qi)它媒(mei)體,轉(zhuan)載(zai)目的(de)在于更好(hao)服務讀者(zhe)(zhe)、傳(chuan)遞(di)信息之需,并不(bu)(bu)代表(biao)本(ben)(ben)網(wang)贊同其(qi)(qi)觀點(dian),本(ben)(ben)網(wang)亦不(bu)(bu)對其(qi)(qi)真實性負責(ze),持異(yi)議者(zhe)(zhe)應與原(yuan)出(chu)處單位主(zhu)張權利(li)(li)。
特別鏈接:政府部門交易機構證券期貨四所兩司新聞發布平臺友情鏈接版權聲明
關于報社關于本站廣告發布免責條款
中國證券報社版權所有,未經書面授權不得復制或建立鏡像 經營許可證編號:京B2-20180749 京公網安備0-1
Copyright 2001-2018 China Securities Journal. All Rights Reserved
中國證券報社(she)版權(quan)所有,未經書(shu)面授(shou)權(quan)不得復制(zhi)或建立鏡(jing)像
經營許可證編號:京B2-20180749 京公網(wang)安備(bei)0-1
Copyright 2001-2018 China Securities Journal. All Rights Reserved